Neurasignal

NeuraSignal is transforming stroke care with real-time access to cerebral blood flow—empowering clinicians to detect and prevent strokes with speed, accuracy, and automation. At the core of our mission is a bold belief: Eliminating stroke begins with real-time brain data, accessible to any provider, anywhere. Powered by AI and robotics, our flagship platform—NovaGuide 2 (NG2)—delivers hands-free, autonomous transcranial Doppler (TCD) exams for the detection of right-to-left shunts (RLS), emboli, and cerebral vasospasm. Why it matters: up to 30% of strokes are cryptogenic, and traditional tools like TTE miss most PFOs. NG2 detects 3x more PFOs than standard echo and identifies 2.7x more treatable shunts, giving clinicians the clarity to act—and patients the chance to prevent a second stroke. Fully reimbursable under existing CPT codes (93886, 93892, 93893), NG2 brings diagnostic-grade neurovascular imaging to hospitals, ASCs, stroke centers, and rural clinics—without relying on specialized techs. Join us in redefining stroke care. Because better brain health starts with blood flow at your fingertips.